Green Chemistry at Glyx Therapeutics: Join Us at the Sustainable Day in Amiens on November 5, 2026
September 2026 — Amiens, France At Glyx Therapeutics, our molecule, an anionic lipidic oligosaccharide, targets Alzheimer’s disease and tauopathies. Our innovation does not stop there: we are developing the production of this molecule at pharmaceutical (GMP) grade, entirely following green chemistry principles, with electrosynthesis and mechanosynthesis. Sustainable Day, Amiens, November 5, 2026 Glyx Therapeutics will […]
